Products
Protects Against Cold & Flu Viruses
ColdZyme® is a mouth spray that protects against viruses in the upper respiratory tract that cause colds and flu-like symptoms. It acts quickly by creating a protective barrier in the mouth and throat to block viruses before they can cause an infection. The unique formula not only helps to prevent colds but also alleviates symptoms if you are already feeling unwell.
ColdZyme® has a triple action:
PROTECTS against viruses that cause cold and flu-like symptoms.
Helps SHORTEN THE DURATION of cold & flu symptoms when used at an early stage of infection.
ALLEVIATES common cold and flu-like symptoms, such as sore throat
Deactivates viruses - helping fight infections before they take hold
ColdZyme® is unique because it directly targets the viruses that cause colds and flu-like symptoms.
Catches: ColdZyme® forms a protective layer in your throat, catching harmful viruses that cause colds and flu-like symptoms.
Disables: Once captured, ColdZyme® helps block the viruses from attaching to your cells, stopping them from spreading in your body.
Protects: ColdZyme® coats and moisturizes your throat, offering ongoing protection and soothing relief from symptoms.
For those that cannot afford to be sick
ColdZyme® has a unique defensive action that puts people in control of their upper respiratory health. This is especially important for those that cannot afford to be sick. From doctors and emergency service personnel to athletes in training and the immuno-compromised - ColdZyme can help defend against cold & flu viruses.
ColdZyme® mouth spray is suitable for adults and children over 4 years of age.
ColdZymeⓇ is a CE-marked medical device (MDR Class III).
Scientifically proven
The efficacy and action of ColdZyme has been proven through a number of different scientific studies and clinical investigations. Read more about the included studies here.
Socioeconomic benefits
The potential socioeconomic effect of ColdZyme on the Swedish population suggests the reduction in illness would contribute to an overall health economic gain.
A reduction of just one day of illness would result in an annual SEK 1.4 billion boost for society. This is based on 10 percent of the 4.7 million full-time employed adults in Sweden.1
1Studie av den samhällsekonomiska effekten för den svenska befolkningen vid användning av ColdZyme Munspray, Nordic Evaluation Group AB (Nordeg) på uppdrag av Enzymatica 2013
More about Coldzyme®
For more information please visit the product website: ColdZyme